The FDA-approved drug Alectinib compromises SARS-CoV-2 nucleocapsid phosphorylation and inhibits viral infection in vitro
Work
Year: 2020
Type: preprint
Abstract: ABSTRACT While vaccines are vital for preventing COVID-19 infections, it is critical to develop new therapies to treat patients who become infected. Pharmacological targeting of a host factor required... more
Institutions Cornell University, Weill Cornell Medicine, Tri-Institutional PhD Program in Chemical Biology, Rockefeller University, Memorial Sloan Kettering Cancer Center +8 more
Cites: 80
Cited by: 59
Related to: 10
Citation percentile (by year/subfield): 91.16
Subfield: Infectious Diseases
Field: Medicine
Domain: Health Sciences
Sustainable Development Goal Good health and well-being
Open Access status: green